Tag: genomics
-
Portable Sequencer Identifies Drug-Resistant Bacteria
Researchers using a hand-held genomic sequencing device were able to identify targets for combating drug-resistant bacteria much faster than current methods.
-
Fitbit Devices Providing Precision Medicine Data
Wearers of Fitbit activity tracking devices now have the option of sharing their data with a large-scale precision medicine project run by National Institutes of Health.
-
Designing Strawberry Varieties for Japanese Farms
An agricultural genomics company in Israel and auto maker Toyota began a joint project to design new varieties of strawberries to grow on Japanese farms
-
RNA Therapy Studied for Parkinson’s Side Effects
Medical researchers are developing a treatment for a frequent side-effect of Parkinson’s disease drugs using a corrective RNA molecule to reverse the condition.
-
Crispr Deployed to Stop Disease, Pest Insects
A genetics lab is using the genome editing technique Crispr to create sterilized male insects, which can lead to fewer disease-spreading and farm pest insects.
-
Trial Testing DNA Antibody Vaccine for Zika
A clinical trial is enrolling participants testing a vaccine to prevent Zika infections with synthetic DNA particles designed to produce antibodies against the virus.
-
Algorithms Identify More Genetic Syndromes
An analysis of facial images with computer vision and deep learning returned more accurate identifications of genetic syndromes than 3 panels of trained clinicians
-
Genetic Acids Harnessed to Promote Wound Healing
A bioengineering team designed a way to use acids in DNA that in lab tests promote wound repair by encouraging production of healing proteins in surrounding tissues.
-
Tissue Chip, A.I. Companies Partner on Heart Drug Discovery
A developer of chip devices emulating heart tissue and a medical analytics company using artificial intelligence are jointly discovering new drugs to treat aging heart muscles.
-
Lilly Buys Precision Cancer Company in $8B Deal
Drug maker Eli Lilly and Company is acquiring a developer of cancer therapies that target specific genetic alterations rather than tumors in the body.